IL-2 concentration is low in compartments where vascular density is at baseline; when vascular density is increased, IL-2 concentration also increases, especially when T cells are recruited closer to cancer cells (case B tumor core and case C invasive front), in which case T cells have higher chance of being further activated by tumor neoantigens. This evidence concerns the gene IL2 and cancer.